Carrie Parrish Nyekan, APRN
Family · Bowling Green, KYNPI 1104107473
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (54.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Bayer accounts for 66.7% of it on its own, with 37 other manufacturers making up the rest. Reporting peaked in 2022 at $27,129 and has fallen 86.5% since, to $3,664 in 2025. Among family clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,103 payments — averaging $50.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$37K
- Mannkind Corporation$5K
- Novo Nordisk$2K
- Amgen$1K
- Lilly USA, LLC$1K
- Insulet Corporation$1K
- plus $7K from 32 others
What the payments were for
- Consulting fees$9522%
- Speaking & faculty fees$29,97654%
- Travel & lodging$7,93614%
- Food & beverage$16,43730%
- Education$1210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 126 | $36,956 |
| Mannkind Corporation | 101 | $5,146 |
| Novo Nordisk | 149 | $1,858 |
| Amgen(2 entities) | 106 | $1,454 |
| Lilly USA, LLC | 84 | $1,388 |
| Insulet Corporation | 80 | $1,379 |
| Boehringer Ingelheim | 77 | $1,186 |
| Corcept Therapeutics | 48 | $810 |
| Novartis | 61 | $774 |
| Medtronic | 50 | $690 |
| AstraZeneca(2 entities) | 33 | $568 |
| Abbott | 20 | $322 |
| Tandem Diabetes Care, Inc. | 25 | $313 |
| Dexcom, Inc. | 15 | $301 |
| Sanofi-aventis U.S. LLC | 20 | $287 |
| Amarin Pharma, Inc. | 18 | $286 |
| Merck | 12 | $168 |
| Radius Health, Inc. | 9 | $164 |
| Kowa Pharmaceuticals America, Inc. | 9 | $153 |
| Kyowa Kirin, Inc. | 7 | $146 |
| RGH Enterprises LLC | 4 | $133 |
| Sequel Med Tech, LLC | 6 | $133 |
| Xeris Pharmaceuticals, Inc. | 7 | $131 |
| Esperion Therapeutics, Inc. | 7 | $117 |
| AbbVie | 7 | $116 |
| Amphastar Pharmaceuticals, Inc. | 4 | $75 |
| Amneal Pharmaceuticals LLC | 3 | $59 |
| Ultragenyx Pharmaceutical Inc. | 4 | $58 |
| IBSA Pharma Inc. | 1 | $45 |
| Madrigal Pharmaceuticals | 2 | $44 |
| Cequr Corporation | 1 | $43 |
| BD | 1 | $29 |
| Amryt Pharma Holdings Ltd | 1 | $19 |
| Acella Pharmaceuticals, LLC | 1 | $18 |
| Halozyme Inc | 1 | $15 |
| Antares Pharma, Inc. | 1 | $14 |
| Ascendis Pharma Endocrinology Inc | 1 | $14 |
| Zealand Pharma US, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$55,422 in reported general payments places this provider in the 95th percentile of 4,374 family providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 644 | $813,687 |
| MounjaroTirzepatide | 418 | $491,589 |
| FarxigaDapagliflozin Propanediol | 384 | $380,416 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 191 | $324,363 |
| Tresiba Flextouch U-200Insulin Degludec | 263 | $321,887 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 138 | $317,484 |
| JardianceEmpagliflozin | 271 | $259,005 |
| TrulicityDulaglutide | 145 | $235,079 |
| KerendiaFinerenone | 164 | $148,410 |
| Tresiba Flextouch U-100Insulin Degludec | 148 | $125,480 |
| Repatha SureclickEvolocumab | 76 | $84,313 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 59 | $76,373 |
| Humalog Kwikpen U-100Insulin Lispro | 202 | $75,000 |
| RybelsusSemaglutide | 50 | $73,179 |
| JanuviaSitagliptin Phosphate | 82 | $68,022 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus, Novolog, Fiasp, Tresiba | $1,858 | $972,511864 claims |
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $1,388 | $748,186629 claims |
| AstraZenecaFarxiga | $568 | $380,416384 claims |
| Boehringer IngelheimJardiance, Tradjenta | $1,186 | $286,650320 claims |
| BayerKerendia | $36,956 | $148,410164 claims |
| MerckJanuvia | $168 | $68,02282 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33, Lantus | $287 | $35,08246 claims |
| AbbVieSynthroid | $116 | $28,793383 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $59 | $9,758942 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,374 family providers in Kentucky.
Other family in Bowling Green
- Cory GearldsBowling Green$51K
- Jeannette DabitBowling Green$28K
- Shellie HardcastleBowling Green$15K
- Ashley ToweBowling Green$14K
- Ayme RowlandBowling Green$14K
- Jenna PoteetBowling Green$14K
- Jacqueline ErbseBowling Green$14K
- Krista NealBowling Green$12K
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.